反应详情

To a solution of N-((1S)-1-{[4-(bromoacetyl)phenyl]methyl}-3-hydroxypropyl)-3-cyano-4-[(1-methylethyl)oxy]benzamide (300 mg, 0.634 mmol) in i-PrOH (6 mL) was added 2-amino-3-picoline (Aldrich, 69 mg, 0.634 mmol) followed by solid NaHCO3 (64 mg, 0.761 mmol). The resultant suspension was heated to 80° C. After 7 h, a majority of the i-PrOH was removed under reduced pressure and the residue was dissolved in 3% MeOH/EtOAc (30 mL) and washed with water (10 mL) and brine (10 mL). The combined aqueous layers were extracted with 3% MeOH/EtOAc (30 mL) and the combined extracts were dried (Na2SO4), filtered and concentrated under reduced pressure. The residue was purified by reverse phase HPLC (MeCN/H2O with 0.1% TFA) and the clean fractions were adjusted to pH ˜8 with saturated aqueous NaHCO3 and extracted with 3% MeOH/EtOAc (3×30 mL). The extracts were dried (Na2SO4), filtered and concentrated under reduced pressure to give 215 mg (70%) of the title compound as a pale yellow solid.

1. customa majority of the i-PrOH was removed under reduced pressure
2. dissolutionthe residue was dissolved in 3% MeOH/EtOAc (30 mL)
3. washwashed with water (10 mL) and brine (10 mL)
4. extractionThe combined aqueous layers were extracted with 3% MeOH/EtOAc (30 mL)
5. dry with materialthe combined extracts were dried (Na2SO4)
6. filtrationfiltered
7. concentrationconcentrated under reduced pressure
8. customThe residue was purified by reverse phase HPLC (MeCN/H2O with 0.1% TFA)
9. extractionextracted with 3% MeOH/EtOAc (3×30 mL)
10. dry with materialThe extracts were dried (Na2SO4)
11. filtrationfiltered
12. concentrationconcentrated under reduced pressure